An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.

Saved in:
Bibliographic Details
Title: An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.
Authors: Kent OA; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Sandí MJ; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Burston HE; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Brown KR; Donnelly Centre and Banting and Best Department of Medical Research, University of Toronto, Toronto, Canada., Rottapel R; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada.; Department of Medicine, St. Michael's Hospital, Toronto, Canada.; Department of Medical Biophysics, St. Michael's Hospital, Toronto, Canada.; Department of Immunology, St. Michael's Hospital, Toronto, Canada.; Division of Rheumatology, St. Michael's Hospital, Toronto, Canada.
Source: Oncotarget [Oncotarget] 2017 Jan 17; Vol. 8 (3), pp. 4484-4500.
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.13152